Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.

Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.

Since World War II, antibiotics have been the most effective factor in longevity and population expansion. Today, loss of effective antibiotics threatens their medical institutions – antibiotic resistance is a serious problem already or will be within the decade. Doctors, in the US and UK, have reported that they now have less than a handful effective antibiotics for some pathogens. In the EU alone, infections with multidrug resistant bacteria cause around 25,000 deaths each year and the associated economic burden is immense. Still in today’s world, more infants and children are dying from pneumonia than from malaria.

Quratis, Inc. engages in the research and development of medicine and pharmaceutical products. Its businesses include vaccines, cell therapy platform, peptide nucleic acid, contract development, and manufacturing services. The company was founded on July 15, 2016 and is headquartered in Seoul, South Korea.

BioApp is a biotechnology company that aims to provide a plant-derived genetically modified subunit vaccine for swine fever prevention. The company conducts research and development of plant-based green vaccine products for swine fever and African swine fever, as well as human medicines like Corona 19.

GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

Part of AbbVie, Inc., Balkanpharma Razgrad AD is a Bulgarian company located in Razgrad. The firm manufactures pharmaceuticals.

IFB is a human-sized company specializing in the edition of Cash Office, cash and management software.

Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. is a Japanese company located in Katsuyama. The firm develops, manufactures, and sells pharmaceuticals. On June 30, 2002 Abbott Laboratories acquired Hokuriku Seiyaku Co., Ltd. for $291.31 million.

At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems. A royal commission, entitled The Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis, was set up in 1901. It aimed to find out whether tuberculosis in animals and humans was the same disease and whether animals and humans could infect each other. This page describes how, by 1919, the Commission had evolved into the independent Medical Research Council.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Comercial Jope SL is a private company headquartered in Spain. The firm manufactures other components, parts and accessories for motor vehicles.